Validation of a French version of a questionnaire for dentin hypersensitivity
Validation of a French Version of the DHEQ - Oral Health-related Quality of Life and Dentin Hypersensitivity
NA · University Hospital, Clermont-Ferrand · NCT06466200
This study is testing a French questionnaire to see how dentin hypersensitivity affects people's lives and help doctors diagnose the condition better.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 216 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University Hospital, Clermont-Ferrand (other) |
| Locations | 3 sites (Bordeaux and 2 other locations) |
| Trial ID | NCT06466200 on ClinicalTrials.gov |
What this trial studies
This study aims to validate the French version of the Dentin Hypersensitivity Experience Questionnaire (DHEQ-fr) through a multicenter approach involving three centers in France. The DHEQ-fr is designed to assess the impact of dentin hypersensitivity on patients' quality of life and to aid in the diagnosis of this condition. Participants will complete the DHEQ-fr along with other questionnaires to compare results and ensure comprehensive evaluation. The study will involve adult patients who meet specific inclusion criteria and will exclude those with certain dental conditions or recent treatments.
Who should consider this trial
Good fit: Ideal candidates for this study are adults experiencing dentin hypersensitivity who can understand the study requirements.
Not a fit: Patients with other dental pathologies or those who have recently undergone specific dental treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a validated tool for better diagnosing and managing dentin hypersensitivity, ultimately improving patients' quality of life.
How similar studies have performed: While the DHEQ has been validated in other languages, the validation of the French version is a novel approach that has not been previously tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who are able to understand the study Exclusion Criteria: * Teeth with other pathologies in addition to HD (carious lesions, cracked enamel, etc.); * Abutment teeth for fixed or removable dentures and crown teeth; * Teeth with restorations involving the inner third of the dentin and/or restorations involving the dentinary/root exposure area; * Patients who have been on or have undergone desensitizing therapy for HD in the past three months; * Patients who have received periodontal surgery within the last three months; * Patients with orthodontic devices who have interrupted orthodontic treatment in the last three months; * Pregnant or breastfeeding patients; * Patients under guardianship, curatorship, safeguard of justice * Patients deprived of liberty * Patients participating in any other clinical study.
Where this trial is running
Bordeaux and 2 other locations
- CHU de Bordeaux — Bordeaux, France (RECRUITING)
- CHU de Clermont-Ferrand — Clermont-Ferrand, France (RECRUITING)
- Centre de soins bucco-dentaires — Lyon, France (RECRUITING)
Study contacts
- Principal investigator: Sophie Domejean — CHU de Clermont-Ferrand
- Study coordinator: Lise Laclautre
- Email: promo_interne_drci@chu-clermontferrand.fr
- Phone: +334754963
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Dentin Hypersensitivity, Quality of Life, Oral health